Related Experiment Video

Updated: Apr 20, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

536

The emerging roles of microRNAs in cancer metabolism

Brian Chan1, Jacob Manley, Jae Lee

  • 1Basic Research Laboratory, Stem Cell Regulation and Animal Aging Section, National Cancer Institute, Frederick, MD 21702, USA.

Cancer Letters
|December 3, 2014
PubMed

Insights

Cancer cells reprogram metabolism, making them hard to target. MicroRNAs (miRNAs) influence these metabolic pathways, offering potential new therapeutic strategies for cancer treatment and understanding tumorigenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cancer therapy aims to eliminate malignant cells while sparing healthy ones.
  • Cancer cells exhibit significant heterogeneity and adaptability, complicating targeted treatments.
  • Metabolic reprogramming is a hallmark of cancer, driving its growth and survival.

Purpose of the Study:

  • To explore the intricate relationship between microRNAs (miRNAs) and cancer cell metabolism.
  • To elucidate how specific miRNAs regulate metabolic pathways crucial for tumorigenesis.
  • To identify potential therapeutic targets by understanding miRNA-mediated metabolic control in cancer.

Main Methods:

  • Review of current literature on microRNAs and cancer metabolism.
  • Analysis of known miRNA interactions with key metabolic genes.
  • Examination of how miRNA dysregulation impacts metabolic pathways in cancer cells.

Main Results:

  • MicroRNAs are confirmed regulators of diverse metabolic pathways in cancer.
  • Specific miRNAs can either promote or inhibit metabolic processes essential for tumor growth.
  • Understanding these miRNA-metabolism links provides insights into cancer's adaptability.

Conclusions:

  • MicroRNAs play a critical role in cancer's metabolic reprogramming.
  • Targeting miRNA-metabolism interactions presents a promising avenue for novel cancer therapies.
  • Further research into these connections could deepen our understanding of tumorigenesis.

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.1K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
25.1K
MicroRNAs01:22

MicroRNAs

12.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K